PSCA anticorps
-
- Antigène Voir toutes PSCA Anticorps
- PSCA (Prostate Stem Cell Antigen (PSCA))
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PSCA est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Attributs du produit
- Polyclonal Antibody
- Purification
- Antigen affinity purification
- Immunogène
- Synthetic peptide of human PSCA
- Isotype
- IgG
- Top Product
- Discover our top product PSCA Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000, IHC 1:20-1:100, ELISA 1:5000-1:10000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.78 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- PSCA (Prostate Stem Cell Antigen (PSCA))
- Autre désignation
- PSCA (PSCA Produits)
- Synonymes
- anticorps PRO232, anticorps 2210408B04Rik, anticorps PSCA, anticorps prostate stem cell antigen, anticorps PSCA, anticorps Psca, anticorps LOC482068
- Sujet
- PSCA (Prostate Stem Cell antigen) is a cell surface antigen, which is overexpressed in ~40 % of primary prostate cancers and in as many as 100 % of metastatic ones. PSCA is also overexpressed in a majority of transitional cell and pancreatic carcinomas. Antibody directed against PSCA inhibits tumorigenesis, slows tumor growth, prolongs survival and prevents metastasis in a preclinical zenograft model indicating that PSCA may have utility as a prognostic marker and/or therapeutic target in prostate cancer.
- Poids moléculaire
-
Observed_MW: Refer to figures
Calculated_MW: 13 kDa
- UniProt
- O43653
-